Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00873600
What this trial is testing

Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+1 more
Case Comprehensive Cancer Center
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableUnknownNCT05307757
What this trial is testing

Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Seoul National University Hospital 1,098
Large-scale testing (Phase 3)WithdrawnNCT00695916
What this trial is testing

MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery

Who this might be right for
Breast Cancer
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Early research (Phase 1)Ended earlyNCT00754312
What this trial is testing

A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Syndax Pharmaceuticals 1
Not applicableEnded earlyNCT01144754
What this trial is testing

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

Who this might be right for
LymphomaNon-Hodgkin's Lymphoma
Stanford University 1
Not applicableStudy completedNCT00755313
What this trial is testing

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more
University of California, San Francisco 81
Very early researchWithdrawnNCT04630210
What this trial is testing

Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven
Not applicableStudy completedNCT00766454
What this trial is testing

Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 1,104
Testing effectiveness (Phase 2)Study completedNCT02520063
What this trial is testing

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 15
Not applicableUnknownNCT05388734
What this trial is testing

Shared Decision Making on Care Pathways and CAMs: A Pilot Study

Who this might be right for
Breast CancerNon-metastaticNewly Diagnosed+1 more
University Hospital, Grenoble 100
Testing effectiveness (Phase 2)Study completedNCT01763931
What this trial is testing

DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Not applicableStudy completedNCT01941784
What this trial is testing

Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage II Breast Cancer+4 more
Wake Forest University Health Sciences 28
Not applicableStudy completedNCT00656669
What this trial is testing

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

Who this might be right for
Breast Cancer
Indiana University 23
Testing effectiveness (Phase 2)Ended earlyNCT01512199
What this trial is testing

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Daiichi Sankyo 29
Early research (Phase 1)Study completedNCT00005886
What this trial is testing

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02562118
What this trial is testing

Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
National University Hospital, Singapore 40
Testing effectiveness (Phase 2)Ended earlyNCT03697551
What this trial is testing

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Ipsen 4
Not applicableStudy completedNCT03350854
What this trial is testing

Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Utah 100
Next Page